Cargando…

Usefulness of FDG-PET/CT-Based Radiomics for the Characterization and Genetic Orientation of Pheochromocytomas Before Surgery

SIMPLE SUMMARY: Around 40% of patients with pheochromocytomas (PHEO) carry a germline mutation. Early germline mutation identification is important for accurate treatment and follow-up in affected patients. The aim of our retrospective study was to assess the potential added value of FDG-PET/CT radi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ansquer, Catherine, Drui, Delphine, Mirallié, Eric, Renaudin-Autain, Karine, Denis, Antoine, Gimenez-Roqueplo, Anne-Paule, Leux, Christophe, Toulgoat, Frederique, Kraeber-Bodéré, Françoise, Carlier, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565830/ https://www.ncbi.nlm.nih.gov/pubmed/32859070 http://dx.doi.org/10.3390/cancers12092424

Ejemplares similares

Carcinoembryonic Antigen Increase in a Patient with Colon Cancer Who Have Achieved Complete Remission and Negative (18)F-FDG PET/CT: Don’t Forget the Thyroid!
por: Lugat, Alexandre, et al.
Publicado: (2021)

Pheochromocytomas and secreting paragangliomas
por: Plouin, Pierre-François, et al.
Publicado: (2006)

Quantitative Evaluation of Therapeutic Response by FDG-PET–CT in Metastatic Breast Cancer
por: Goulon, Dorothée, et al.
Publicado: (2016)

Revisiting the Robustness of PET-Based Textural Features in the Context of Multi-Centric Trials
por: Bailly, Clément, et al.
Publicado: (2016)

Performance of baseline FDG-PET/CT radiomics for prediction of bone marrow minimal residual disease status in the LyMa-101 trial
por: Bodet-Milin, Caroline, et al.
Publicado: (2023)

Interest of FDG-PET in the Management of Mantle Cell Lymphoma
por: Bailly, Clément, et al.
Publicado: (2019)

Prognostic value of FDG-PET indices for the assessment of histological response to neoadjuvant chemotherapy and outcome in pediatric patients with Ewing sarcoma and osteosarcoma
por: Bailly, Clement, et al.
Publicado: (2017)

Assessment of acquisition protocols for routine imaging of Y-90 using PET/CT
por: Carlier, Thomas, et al.
Publicado: (2013)

Exploring Tumor Heterogeneity Using PET Imaging: The Big Picture
por: Bailly, Clément, et al.
Publicado: (2019)

FDG-PET/CT, a Promising Exam for Detecting High-Risk Myeloma Patients?
por: Michaud-Robert, Anne-Victoire, et al.
Publicado: (2020)

Initial FDG-PET/CT predicts survival in adults Ewing sarcoma family of tumors
por: Jamet, Bastien, et al.
Publicado: (2017)

FDG-PET in Follicular Lymphoma Management
por: Bodet-Milin, C., et al.
Publicado: (2012)

Clinical and Survival Impact of FDG PET in Patients with Suspicion of Recurrent Ovarian Cancer: A 6-Year Follow-Up
por: Rusu, Daniela, et al.
Publicado: (2015)

The Warburg Effect Is Genetically Determined in Inherited Pheochromocytomas
por: Favier, Judith, et al.
Publicado: (2009)

Challenges in Nuclear Medicine: Innovative Theranostic Tools for Personalized Medicine
por: Kraeber-Bodéré, Françoise, et al.
Publicado: (2014)

Specific features to differentiate Giant cell arteritis aortitis from aortic atheroma using FDG-PET/CT
por: Espitia, Olivier, et al.
Publicado: (2021)

Vascular Pattern Analysis for the Prediction of Clinical Behaviour in Pheochromocytomas and Paragangliomas
por: Oudijk, Lindsey, et al.
Publicado: (2015)

[(18)F]FDG-PET/CT radiomics for the identification of genetic clusters in pheochromocytomas and paragangliomas
por: Noortman, Wyanne A., et al.
Publicado: (2022)

Glucose Metabolism Quantified by SUVmax on Baseline FDG-PET/CT Predicts Survival in Newly Diagnosed Multiple Myeloma Patients: Combined Harmonized Analysis of Two Prospective Phase III Trials
por: Michaud-Robert, Anne-Victoire, et al.
Publicado: (2020)

Prospective Multicentric Assessment of (68)Ga-DOTANOC PET/CT in Grade 1-2 GEP-NET
por: Lugat, Alexandre, et al.
Publicado: (2023)

Highlights lecture EANM 2016: “Embracing molecular imaging and multi-modal imaging: a smart move for nuclear medicine towards personalized medicine”
por: Aboagye, Eric O., et al.
Publicado: (2017)

Incidental findings suggestive of COVID-19 in asymptomatic cancer patients undergoing 18F-FDG PET/CT in a low prevalence region
por: Pallardy, Amandine, et al.
Publicado: (2020)

Prognostic Value and Clinical Impact of (18)FDG-PET in the Management of Children with Burkitt Lymphoma after Induction Chemotherapy
por: Bailly, Clément, et al.
Publicado: (2014)

Assessment of Lymph Nodes and Prostate Status Using Early Dynamic Curves with (18)F-Choline PET/CT in Prostate Cancer
por: Mathieu, Cédric, et al.
Publicado: (2015)

Sensitivity of pretargeted immunoPET using (68)Ga-peptide to detect colonic carcinoma liver metastases in a murine xenograft model: Comparison with (18)FDG PET-CT
por: Foubert, Fanny, et al.
Publicado: (2018)

Clinical Results in Medullary Thyroid Carcinoma Suggest High Potential of Pretargeted Immuno-PET for Tumor Imaging and Theranostic Approaches
por: Bodet-Milin, Caroline, et al.
Publicado: (2019)

From a PMT-based to a SiPM-based PET system: a study to define matched acquisition/reconstruction parameters and NEMA performance of the Biograph Vision 450
por: Carlier, Thomas, et al.
Publicado: (2020)

RF33 | PSUN04 Luteinizing Hormone-Chorionic Gonadotrophin Receptor in Pheochromocytomas
por: Lopez, Antoine-Guy, et al.
Publicado: (2022)

Innovative radiopharmaceuticals in oncology and neurology
por: Kraeber-Bodéré, Françoise, et al.
Publicado: (2017)

Oncogenic features of the bone morphogenic protein 7 (BMP7) in pheochromocytoma
por: Leinhäuser, Ines, et al.
Publicado: (2015)

Semi-Quantitative [(18)F]FDG-PET/CT ROC-Analysis-Based Cut-Offs for Aortitis Definition in Giant Cell Arteritis
por: Espitia, Olivier, et al.
Publicado: (2022)

ImmunoPET to help stratify patients for targeted therapies and to improve drug development
por: Kraeber-Bodere, Françoise, et al.
Publicado: (2016)

Rheumatic involvement and bone scan features in Schnitzler syndrome: initial and follow-up data from a single-center cohort of 25 patients
por: Darrieutort-Laffite, Christelle, et al.
Publicado: (2020)

Imaging of Monoclonal Gammapathy of Undetermined Significance and Smoldering Multiple Myeloma
por: Jamet, Bastien, et al.
Publicado: (2020)

Prognostic Impact of Pretherapeutic FDG-PET in Localized Anal Cancer
por: Le Thiec, Maelle, et al.
Publicado: (2020)

MON-212 Genetic Spectrum Of A Canadian Cohort Of Sporadic Pheochromocytomas And Paragangliomas: Higher Prevalence Of Germline Mutations In PGL And NGS Assay With A Multigene Panel Increases The Mutation Rate
por: Salle, Stefanie Parisien-La, et al.
Publicado: (2020)

International initiative for a curated SDHB variant database improving the diagnosis of hereditary paraganglioma and pheochromocytoma
por: Ben Aim, Laurene, et al.
Publicado: (2022)

[(18)F]-Fludarabine for Hematological Malignancies
por: Barré, Louisa, et al.
Publicado: (2019)

Functional Imaging for Therapeutic Assessment and Minimal Residual Disease Detection in Multiple Myeloma
por: Jamet, Bastien, et al.
Publicado: (2020)

Overexpression of miR‐483‐5p is confined to metastases and linked to high circulating levels in patients with metastatic pheochromocytoma/paraganglioma
por: Castro‐Vega, Luis Jaime, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r95gvdcr4orpln9ficio4036nh